Anti-interferon-beta antibodies in Polish multiple sclerosis patients: prevalence and clinical significance in a long-term prospective study.

Anna PietrzakAlicja Kalinowska-ŁyszczarzKrystyna OsztynowiczAlima KhamidullaWojciech KozubskiSławomir Michalak

Published in: Neurologia i neurochirurgia polska (2019)

Antibodies developed after treatment initiation are associated with a worse outcome. Naturally- occurring antibodies appear to predict more benign disease. Their prevalence and specificity require further investigation.

Keyphrases

multiple sclerosis
end stage renal disease
risk factors
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported